Go Back to Match Results for "trials"

A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required